PharmaShots | Incisive News in 3 Shots

Subscribe Now

IMV

IMV Reports the First Patient Dosing in the P-IIb (VITALIZE) Study for MVP-S + Keytruda (pembrolizumab) for the Treatment of R/R DLBCL

IMV Reports the First Patient Dosing in the P-IIb (VITALIZE) Study for MVP-S + Keytruda (pembrolizumab) for the Treatment of R/R D...

January 13, 2022

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

June 30, 2020

Insights+: COVID-19 Healthcare News Monthly Updates - May 2020

Insights+: COVID-19 Healthcare News Monthly Updates - May 2020

May 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us